The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 26, 2014

Filed:

Apr. 04, 2005
Applicants:

Dieter Dorsch, Ober-Ramstadt, DE;

Rolf Gericke, Seeheim-Jugenheim, DE;

Werner Mederski, Zwingenberg, DE;

Norbert Beier, Reinheim, DE;

Florian Lang, Tuebingen, DE;

Inventors:

Dieter Dorsch, Ober-Ramstadt, DE;

Rolf Gericke, Seeheim-Jugenheim, DE;

Werner Mederski, Zwingenberg, DE;

Norbert Beier, Reinheim, DE;

Florian Lang, Tuebingen, DE;

Assignee:

Merck Patent GmbH, Darmstadt, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/421 (2006.01); A61K 31/422 (2006.01); A61K 31/416 (2006.01); A61K 31/4178 (2006.01); A61K 31/341 (2006.01); C07D 413/00 (2006.01); C07D 413/02 (2006.01); C07D 233/54 (2006.01); C07D 231/56 (2006.01); C07D 307/34 (2006.01);
U.S. Cl.
CPC ...
A61K 31/421 (2013.01); A61K 31/422 (2013.01); A61K 31/416 (2013.01); A61K 31/4178 (2013.01); A61K 31/341 (2013.01); C07D 413/00 (2013.01); C07D 413/02 (2013.01); C07D 233/54 (2013.01); C07D 231/56 (2013.01); C07D 307/34 (2013.01);
Abstract

Novel heterocyclic compounds of the formula (I), in which R, D, W, T and T' have the meanings indicated in Claim, are SGK inhibitors and can be used for the treatment of SGK-induced diseases and conditions, such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and kidney diseases, generally in fibroses and inflammatory processes of any type.


Find Patent Forward Citations

Loading…